Novartis receives EU approval for first-line use of Zykadia® in ALK-positive advanced non-small cell lung cancer (NSCLC)

World News: . []

Novartis International AG Novartis LINK  EU approval for first-line use of Zykadia in ALK-positive
advanced
non-small cell lung cancer NSCLC LINK  and transmitted by Nasdaq Corporate SolutionsThe LINK  is solely responsible for t he cont...

More news and information about Novartis International AG

Published By:

Thomson Reuters: 06:15 GMT Thursday 29th June 2017

Published: .

Search for other references to "novartis" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us